» Articles » PMID: 15300008

Wnt Proteins in Mammary Development and Cancer

Overview
Date 2004 Aug 10
PMID 15300008
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Secreted proteins of the Wnt family play widespread roles in the regulation of embryonic development, and aberrant activation of the canonical Wnt/beta-catenin pathway is one of the most frequent signaling abnormalities known in human cancer. While the consequences of Wnt signaling in development are diverse at the cellular level, they are often concerned with cell fate determination. Recent data also indicate that Wnt proteins influence the self-renewal of stem cells in certain tissues. In the mammary gland, Wnt signals are strongly implicated in initial development of the mammary rudiments, and in the ductal branching and alveolar morphogenesis that occurs during pregnancy. Transgenic expression of Wnt1 or Wnt10b in the mouse mammary gland leads to lobuloalveolar hyperplasia with a major risk of progression to carcinoma. Recent evidence suggests that this phenotype is associated with expansion of a multipotent progenitor cell population. In human breast cancer, evidence of beta-catenin accumulation implies that the canonical Wnt signaling pathway is active in over 50% of carcinomas. However, specific mutations that might account for this activation of signaling have not yet been identified.

Citing Articles

Genetic landscape of breast cancer subtypes following radiation therapy: insights from comprehensive profiling.

Wang F, Wang W, Wang M, Chen D Front Oncol. 2024; 14:1291509.

PMID: 38380359 PMC: 10878167. DOI: 10.3389/fonc.2024.1291509.


Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/β-catenin pathway.

Wu Y, Li S, Liu J, Xue J, Xu J, Chen T Cell Death Dis. 2023; 14(10):696.

PMID: 37875515 PMC: 10598275. DOI: 10.1038/s41419-023-06214-z.


Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways.

Liu L, Xiao B, Hirukawa A, Smith H, Zuo D, Sanguin-Gendreau V Proc Natl Acad Sci U S A. 2023; 120(33):e2303010120.

PMID: 37549258 PMC: 10438390. DOI: 10.1073/pnas.2303010120.


Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireview.

Tavakoli A, Kahrizi M, Safa K, Arefnezhad R, Rezaei-Tazangi F Mol Biol Rep. 2022; 49(9):9017-9022.

PMID: 35941415 DOI: 10.1007/s11033-022-07739-w.


The role of epigenetic modifications in drug resistance and treatment of breast cancer.

Karami Fath M, Azargoonjahromi A, Kiani A, Jalalifar F, Osati P, Akbari Oryani M Cell Mol Biol Lett. 2022; 27(1):52.

PMID: 35764927 PMC: 9238060. DOI: 10.1186/s11658-022-00344-6.


References
1.
Lin T, Guzman R, OSBORN R, Thordarson G, Nandi S . Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Cancer Res. 1992; 52(16):4413-9. View

2.
Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R . The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell. 1987; 50(4):649-57. DOI: 10.1016/0092-8674(87)90038-9. View

3.
Nusse R, Varmus H . Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982; 31(1):99-109. DOI: 10.1016/0092-8674(82)90409-3. View

4.
Veeman M, Axelrod J, Moon R . A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell. 2003; 5(3):367-77. DOI: 10.1016/s1534-5807(03)00266-1. View

5.
Christiansen J, Dennis C, Wicking C, Monkley S, Wilkinson D, Wainwright B . Murine Wnt-11 and Wnt-12 have temporally and spatially restricted expression patterns during embryonic development. Mech Dev. 1995; 51(2-3):341-50. DOI: 10.1016/0925-4773(95)00383-5. View